Nazli Dizman, MD

Nazli Dizman, MD is an Internal Medicine Resident at Yale School of Medicine specializing in urology.

Articles by Nazli Dizman, MD

Pembrolizumab Plus Axitinib and the Future of Further-line mRCC Treatments

Nazli Dizman, MDAdvanced Renal Cell Carcinoma | May 18, 2023

Dr. Dizman describes the potential of future trials testing novel immunotherapy combinations for treating mRCC.

Pembrolizumab Plus Axitinib in the Second-line and Beyond for mRCC

Nazli Dizman, MDAdvanced Renal Cell Carcinoma | May 18, 2023

Dr. Dizman describes the factors that may contribute to positive outcomes in patients receiving pembrolizumab/axitinib.